Innova Captab Limited

INNOVACAP NSE Healthcare Pharmaceuticals
₹1,153.00
-1.23%
Delayed · cached 15 min

Fair value analysis

INNOVACAP
Innova Captab Limited
HealthcarePharmaceuticals
₹1,167.40
Close used for this calculation
₹733.15Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
50/100
Profitability19/25
Returns6/25
Balance Sheet17/25
Efficiency8/25
Growth12/25
Good
Quality radar
50Prof.19/25Ret.6/25Eff.8/25B.Sht17/25Growth12/25

Consensus fair value

₹733.15
Above FV
▼ -37.2% against the close used
Model range ₹194.13 – ₹1,109.23
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹194.13Fair value₹733.15Bull₹1,109.23
FairClose
52-week traded range
52W low ₹644.7552W high ₹1,188.70

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Innova Captab Limited closed at ₹1,167.40, 59.2% above the consensus fair value of ₹733.15 drawn from 9 valuation models.

Financial DNA score 50/100 — Good. P/E of 42.6x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹194.13
-83.4%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹343.28
-70.6%
√(22.5 × EPS × BVPS)
EPS=24.63, BVPS=212.64 · outside Graham range (P/E 42.6, P/B 5.5) — asset-light, treat as a rough floor
Graham Formula
₹1,109.23
-5.0%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=20%, FD=7%
P/E Fair Value
₹879.29
-24.7%
EPS × 35.7x (sector P/E)
EPS=24.63, Sector P/E=35.7x
Peter Lynch (PEG)
₹499.99
-57.2%
EPS × Growth% (PEG = 1 is fair)
EPS=24.63, g=20.3%
EV/EBITDA
₹860.66
-26.3%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=2.88B
Book Value (P/B)
₹409.33
-64.9%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=212.64, ROE=13.7%, g=6%, r=10%
Reverse DCF
₹1,167.40
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 18.8% | Historical: 20.3%
Margin of Safety
₹473.61
-59.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=631.48, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.